Combination of proteasomal inhibitors lactacystin and MG132 induced synergistic apoptosis in prostate cancer cells.
about
A review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingCelastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancerThiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells.New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer.Secretion stimulates intramembrane proteolysis of a secretory granule membrane enzymeThe dynamics of connexin expression, degradation and localisation are regulated by gonadotropins during the early stages of in vitro maturation of swine oocytes.Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases.O-Glycosylation of a Secretory Granule Membrane Enzyme Is Essential for Its Endocytic TraffickingPotential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspectsProteasome inhibitors mechanism; source for design of newer therapeutic agents.Proteasome inhibitor-induced cleavage of HSP90 is mediated by ROS generation and caspase 10-activation in human leukemic cellsBortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.Neoplasia: An Anniversary of Progress.Phosphorylation of WRINKLED1 by KIN10 Results in Its Proteasomal Degradation, Providing a Link between Energy Homeostasis and Lipid Biosynthesis.Autophagy Mechanism, Regulation, Functions, and Disorders
P2860
Q28389391-D6B219CC-2ABD-4D78-B84A-099D0358C04DQ28395095-EF82995A-41A2-45F6-829F-E1BF6E24A8A4Q28487695-B1251066-C514-484F-AC4E-366830D86BAEQ33834181-357C6E3F-80F7-406E-95C8-C8CE7CD15C61Q33920494-B957345C-E786-4D44-92FA-83D8FFE61B35Q34251212-CC59B05C-5048-4430-8614-0CCCE58A88C8Q34827544-C72C246F-94DC-4AFE-ABB3-C1A9CE20F016Q35828472-C5C87942-C332-436E-8030-B630D992034FQ36217769-B540DC77-B7E2-4AD6-B134-BAD747772D23Q36850110-8329AFB4-22DC-47D8-9E75-9ED0B112D93FQ37948056-B840B9FF-672A-40E0-8F40-49A7207E3F1FQ38003334-10677262-1D9A-417F-B0DA-8BC4B739E550Q41026661-6079BADA-1ED7-47C3-AD7B-0C92F3C19163Q41932078-3ECDB78B-6592-4788-9CBF-C499762A09D6Q46932476-48F5D6D7-4F15-4BE0-BBC9-7F9094494D2BQ48044638-38CFFF66-87E9-41DA-BF00-0C854E3AAFCCQ58905406-6EFBA36C-3659-4D02-A4AF-AC9E89CA7281
P2860
Combination of proteasomal inhibitors lactacystin and MG132 induced synergistic apoptosis in prostate cancer cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Combination of proteasomal inh ...... osis in prostate cancer cells.
@en
type
label
Combination of proteasomal inh ...... osis in prostate cancer cells.
@en
prefLabel
Combination of proteasomal inh ...... osis in prostate cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Combination of proteasomal inh ...... osis in prostate cancer cells.
@en
P2093
Dimpu M Patel
Ismail Kaddour-Djebbar
M Vijay Kumar
Robert B Shirley
Ronald W Lewis
Vijayabaskar Lakshmikanthan
P2860
P304
P356
10.1593/NEO.05520
P577
2005-12-01T00:00:00Z